Haemonetics Income Statement (2009-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Dec2022	Apr2023	Jul2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	239.90M	259.77M	265.00M	261.46M	297.49M	305.30M	304.42M	311.33M	318.18M	336.25M	343.29M	336.17M	345.51M	348.54M	330.60M	321.39M	327.31M	338.97M	346.35M	339.38M
Cost of Revenue (Quarter)	117.36M	121.20M	128.69M	119.19M	139.61M	146.59M	148.17M	144.07M	147.67M	158.38M	167.38M	161.25M	158.07M	155.00M	137.55M	129.15M	132.57M	136.58M	148.14M	136.58M
Gross Profit (Quarter)	122.54M	138.56M	136.31M	142.26M	157.88M	158.71M	156.25M	167.26M	170.51M	177.87M	175.91M	174.92M	187.44M	193.55M	193.05M	192.24M	194.74M	202.39M	198.21M	202.80M
Operating items
Amortization - Intangibles (Quarter)	11.40M	12.15M	11.48M	8.37M	8.22M	8.08M	7.97M	7.47M	7.22M	6.91M	10.43M	12.47M	12.26M	12.23M	11.30M	11.39M	11.18M	10.93M	10.49M	10.20M
Research & Development (Quarter)	10.85M	10.04M	13.21M	10.90M	10.90M	12.69M	15.64M	12.65M	12.66M	13.27M	15.86M	14.45M	14.14M	15.83M	18.30M	16.26M	14.87M	14.19M	14.45M	16.20M
Selling, General & Administrative (Quarter)	75.78M	80.73M	92.42M	92.23M	92.03M	94.66M	97.76M	93.48M	115.32M	111.71M	109.26M	108.25M	106.95M	106.46M	115.14M	110.72M	101.61M	109.15M	120.93M	118.94M
Other Operating Expenses (Quarter)					0.38M			7.47M	7.22M	6.91M	20.84M	12.47M	14.65M	12.23M	-11.73M	11.39M	19.77M	11.65M	85.86M	10.20M
Operating Expenses (Quarter)	98.03M	102.91M	117.11M	111.50M	111.15M	115.43M	120.99M	113.61M	135.21M	131.89M	145.96M	135.17M	135.74M	134.52M	121.72M	138.37M	136.25M	134.99M	221.24M	145.34M
Operating Income (Quarter)	24.51M	35.65M	19.20M	30.77M	46.73M	43.28M	35.26M	53.66M	35.30M	45.98M	29.94M	39.76M	51.70M	59.03M	71.33M	53.87M	58.49M	67.40M	-23.02M	57.46M
EBIT (Quarter)	24.51M	35.65M	19.20M	30.77M	46.73M	43.28M	35.26M	53.66M	35.30M	45.98M	29.94M	39.76M	51.70M	59.03M	71.33M	53.87M	58.49M	67.40M	-23.02M	57.46M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	-4.59M	-4.26M	-3.87M	-5.27M	-5.67M	-1.05M	-2.63M	-2.07M	-2.47M	-1.95M	-6.53M	6.96M	-6.99M	-9.11M	-0.60M	-8.70M	-7.21M	-7.42M	-5.37M	-9.88M
Net income details
EBT (Quarter)	19.92M	31.39M	15.33M	25.49M	41.06M	42.22M	32.63M	51.59M	32.83M	44.03M	23.41M	46.71M	44.70M	49.92M	70.74M	45.17M	51.28M	59.98M	-28.40M	47.57M
Tax Provisions (Quarter)	5.10M	8.20M	5.59M	5.62M	7.90M	9.28M	3.20M	10.50M	7.90M	12.79M	3.01M	8.34M	10.87M	12.40M	12.76M	11.10M	12.60M	15.23M	-8.25M	14.60M
Profit After Tax (Quarter)	14.86M	23.42M	9.74M	19.88M	33.20M	37.40M	29.38M	41.04M	24.91M	39.56M	20.37M	38.37M	33.83M	37.49M	57.98M	34.03M	38.68M	44.74M	-20.15M	33.01M
Income from Continuing Operations (Quarter)	14.82M	23.19M	9.74M	19.88M	33.16M	32.94M	29.42M	41.09M	24.93M	31.24M	20.41M	38.37M	33.83M	37.52M	57.98M	34.07M	38.69M	44.74M	-20.15M	32.97M
Consolidated Net Income (Quarter)	14.82M	23.19M	9.74M	19.88M	33.16M	32.94M	29.42M	41.09M	24.93M	31.24M	20.41M	38.37M	33.83M	37.52M	57.98M	34.07M	38.69M	44.74M	-20.15M	32.97M
Income towards Parent Company (Quarter)	14.82M	23.19M	9.74M	19.88M	33.16M	32.94M	29.42M	41.09M	24.93M	31.24M	20.41M	38.37M	33.83M	37.52M	57.98M	34.07M	38.69M	44.74M	-20.15M	32.97M
Net Income towards Common Stockholders (Quarter)	14.82M	23.19M	9.74M	19.88M	33.16M	32.94M	29.42M	41.09M	24.93M	31.24M	20.41M	38.37M	33.83M	37.52M	57.98M	34.07M	38.69M	44.74M	-20.15M	32.97M
Additional items
EPS (Basic) (Quarter)	0.29	0.45	0.19	0.39	0.65	0.65	0.58	0.81	0.49	0.62	0.40	0.75	0.66	0.75	1.15	0.71	0.81	0.96	-0.43	0.73
EPS (Diluted) (Quarter)	0.29	0.45	0.19	0.38	0.64	0.64	0.57	0.80	0.49	0.61	0.40	0.74	0.66	0.74	1.14	0.70	0.81	0.95	-0.43	0.72
Shares Outstanding (Quarter)	51.04M	51.09M	51.05M	51.22M	50.95M	50.51M	50.78M	50.54M	50.73M	50.77M	50.71M	50.94M	50.90M	50.29M	50.33M	48.11M	47.59M	46.79M	47.18M	45.36M
Shares Outstanding (Diluted) (Quarter)	51.46M	51.34M	51.35M	51.68M	51.56M	51.22M	51.42M	51.34M	51.40M	51.45M	51.40M	51.56M	51.24M	50.64M	50.73M	48.35M	47.66M	46.99M	47.35M	45.70M
Shares Outstanding (Entity) (Quarter)	51.06M	51.11M	51.12M	51.32M	50.61M	50.44M	50.45M	50.71M	50.74M	50.79M	50.79M	51.15M	50.38M	50.24M	48.22M	48.16M	46.75M	46.83M	45.25M	45.50M
EBITDA (Quarter)	24.51M	35.65M	19.20M	30.77M	46.73M	43.28M	35.26M	53.66M	35.30M	45.98M	29.94M	39.76M	51.70M	59.03M	71.33M	53.87M	58.49M	67.40M	-23.02M	57.46M
Interest Expenses (Quarter)	11.90M	11.20M	3.10M	0.70M	9.20M	8.50M	11.59M	0.50M	20.29M	32.84M	18.90M	44.16M	44.93M	44.97M	-0.07M	45.27M	43.87M	43.52M	6.70M	40.69M
Tax Rate (Quarter)	25.60%	26.12%	36.45%	22.03%	19.24%	21.98%	9.81%	20.35%	24.06%	29.04%	12.84%	17.85%	24.32%	24.84%	18.03%	24.57%	24.57%	25.40%	29.06%	30.69%

Research Tools

Datasets

Plans

Developers

Haemonetics HAE Income Statement (2009-2026)

Research Tools

Datasets

Plans

Developers

Haemonetics HAE Income Statement (2009-2026)

Create an account

Sign In

Reset Password